Search
Returning search results with filters:
Remove filter for
Issue: Health products
Remove filter for
Last updated: February 2022
Remove filter for
Last updated: 2022
Clear all
Search filters
Type
Audience
Category
Issue
Last updated
Recall class
Displaying 1 - 12 of 12 items.
0.9% Sodium Chloride Injection USP: Leaking solution bag
Solution bags may be leaking in affected lot.
RecallHealth product recall | 2022-02-28
Rapid antigen test kits and potential exposure to hazardous substances
Following an increase in reports to poison control centres, Health Canada is advising Canadians about potential risks associated with the misuse or accidental ingestion or spillage of COVID-19 rapid antigen test kit solutions on the skin. Health Canada…
AlertPublic advisory | 2022-02-24
Distribution of NUVAXOVID with English-only Vial and Carton Labels
NUVAXOVID was authorized by Health Canada on February 17, 2022. In order to provide earlier access to NUVAXOVID in the context of the global pandemic, Novavax, Inc. will distribute product vials, cartons and package inserts that are in English only for a…
AlertHealth professional risk communication | 2022-02-23
Rapid Protectant Hand Sanitizer Gel: labelling
Affected lot(s) may be missing risk statements and the non medicinal ingredient carbomer on the outer label.
RecallHealth product recall | 2022-02-23
Octagam 10% (Immune globulin intravenous, Human):Quality issue
Elevated reporting rate of hypersensitivity reactions in affected lot.
RecallHealth product recall | 2022-02-23
Odan Itraconazole: Out of specification
The assay is out of specification in the affected lot
RecallHealth product recall | 2022-02-23
The Newfoundland Distillery Company - Fighting Spirit: Acetaldehyde outside acceptable limit
The affected lots may contain an acetaldehyde concentration that is outside the acceptable limit.
RecallHealth product recall | 2022-02-08
Alcohol Antiseptic 80% (v/v) Topical Solution Hand Sanitizer: Acetaldehyde outside acceptable limit
The affected lots may contain an acetaldehyde concentration that is outside the acceptable limit.
RecallHealth product recall | 2022-02-08
Auralgan: Impurities out of specification
Impurities could be out of specification in affected lots.
RecallHealth product recall | 2022-02-04
Vitastack: missing risk statement
Affected lot is missing risk statements on the outer label.
RecallHealth product recall | 2022-02-04
BEOVU (brolucizumab) – Risk of Intraocular Inflammation, Retinal Vasculitis and/or Retinal Vascular Occlusion
An increased incidence of intraocular inflammation (IOI), including retinal vasculitis (RV) and retinal vascular occlusion (RO), was observed in patients who received BEOVU 6 mg with every 4 weeks (q4 week) dosing beyond the first 3 doses compared to…
AlertHealth professional risk communication | 2022-02-03
Health Canada warns that products sold by Kerela Ayurvedic & Natural Herbal Consultation in Toronto, ON, may pose serious health risks
UPDATE (February 1, 2022):
Further to its November 25, 2021 advisory, Health Canada is advising consumers that testing of products seized from Kerela Ayurvedic & Natural Herbal Consultation in Toronto, ON, has identified unacceptable levels of…
AlertPublic advisory | 2022-02-01